Browse EX-10 agreements

Execution Version

LIMITED PARENT GUARANTEE

(Remarketing Right)

THIS LIMITED PARENT GUARANTEE (as it may be amended, restated, amended and restated, supplemented or otherwise modified from time to time, this “Agreement”) is entered into as of May 29, 2026, by IREN Limited (ACN 629 842 799), a company incorporated under the laws of Australia (the “Guarantor”) and CSC Delaware Trust Company, in its capacity as collateral agent (together with its successors and assigns appointed pursuant to the Intercreditor Agreement (as defined below), the “Collateral Agent”) for the Financing Parties (as defined in the Intercreditor Agreement).

PRELIMINARY STATEMENTS

…

Certain confidential information contained in this document, marked by [***], has been omitted because IREN Limited (the “Company”) has determined that the information (i) is not material and/or (ii) contains personal information Non-Cancellable Non-Returnable (NCNR) and Supplemental Terms Agreement This Non-Cancellable Non-Returnable and Supplemental Terms Purchase Agreement between IE US Hardware 4 Inc. (“Customer”) and Dell Marketing L.P. (“Dell” or “Supplier”) (“NCNR Agreement”) is effective as of the date of the last signature below (“Effective Date”) and confirms and sets out certain supplementary terms and conditions that will apply to the purchase and use of the products and services set out in the purchase order CHD_NV_DELL_B200_051526, including the related quote(s) attached hereto as Exhibit 1 and/or any related updated, revised or replacement quotes, proposals or purchase orders as agreed between the parties in writing (the “Order”). Capitalized terms used but not defined in this NCNR Agreement have the meaning given to them in the Supply Contract (as defined belo

…

1 IREN Limited Restricted Stock Unit Award Agreement (Directors) This Director Restricted Stock Unit Award Agreement (“Agreement”) is entered into by and between IREN Limited (the “Company”) and the participant whose name appears below (the “Participant”) in order to set forth the terms and conditions of Director Restricted Stock Units (the “DRSUs”) hereby granted to the Participant under the IREN Limited 2025 Omnibus Incentive Plan (the “Plan”). This Agreement includes the terms and conditions of the DRSU grant attached hereto. Participant’s Name: “Date of Grant”: Award Type Number of DRSUs “Vesting Schedule” DRSUs Within ten days after the release of the Company’s annual financial results for the fiscal year ending 30 June 2027, and in any event no later than 31 December of that calendar year. Grant date valuation per DRSU is calculated as the 60-day average closing share price on the last trading day immediately prior to the grant date, being USD$XX.XX. Subject to this Agreement, the terms of the Plan and the terms and conditions of the addendum/addenda applicable to the Participa

…

Execution Version

LIMITED PARENT GUARANTEE

(Managed Services Agreement)

THIS LIMITED PARENT GUARANTEE (as it may be amended, restated, amended and restated, supplemented or otherwise modified from time to time, this “Agreement”) is entered into as of May 29, 2026, by IREN Limited (ACN 629 842 799), a company incorporated under the laws of Australia (the “Guarantor”) and CSC Delaware Trust Company, in its capacity as collateral agent (together with its successors and assigns appointed pursuant to the Intercreditor Agreement (as defined below), the “Collateral Agent”) for the Financing Parties (as defined in the Intercreditor Agreement).

PRELIMINARY STATEMENTS

…

Exhibit 10.49

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

![](a104

Execution Version IE US HARDWARE 3 LLC $2,100,000,000 5.96% Senior Notes due December 31, 2031 ______________ NOTE PURCHASE AGREEMENT ______________ Dated May 29, 2026 Certain confidential information contained in this document, marked by [***], has been omitted because it is both not material and is the type that IREN Limited treats as private or confidential Exhibit 10.36 - i - TABLE OF CONTENTS SECTION HEADING PAGE SECTION 1. AUTHORIZATION OF NOTES ......................................................................................1 SECTION 1.1. Notes ...............................................................................................................1 SECTION 1.2. Collateral .........................................................................................................1 SECTION 1.3. Collateral Agent ..............................................................................................1 SECTION 2. SALE AND PURCHASE OF NOTES ...............................................................................2 SECTION 2.1. Sal

…

WORKSPORT LTD.

2500 N America Dr.

West Seneca, New York 14224

** **

August 27, 2026

Holder of Worksport December 2025 Warrants

Re:	Inducement Offer to Exercise Common Stock Purchase Warrants

Dear Holder:

Worksport Ltd. (the “Company”) is pleased to offer to you (“Holder”, “you” or similar terminology) the opportunity to receive new warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) in consideration for you exercising (i) all of the Common Stock purchase warrants issued by the Company to the Holder on December 12, 2025 (the “Existing Warrants”) at the Reduced Exercise Price (as defined below), as set forth on the signature page hereto.

…

Exhibit 10.1

2006 Route 130 North, Burlington, NJ 08016

Phone: (609) 387-7800 Fax: (609) 239-9675

PERSONAL AND CONFIDENTIAL

July 28, 2026

Via Electronic Mail

Matthew Pasch

Dear Matt:

This letter sets forth the proposal of Burlington Coat Factory Warehouse Corporation (the “Company”) regarding your separation from employment with the Company. Upon your acceptance of the terms and conditions set forth in this Letter Agreement (the “Letter Agreement”) and the General Release attached hereto as Exhibit A (the “Release”), the Company agrees to provide you with the severance package set forth in this Letter Agreement on the conditions described herein. For the purposes of this Letter Agreement, reference to the Company shall also include reference to any or all of Burlington Coat Factory Warehouse Corporation or Burlington Stores, Inc., wherever appropriate or as their interests may appear. Terms referenced but not defined herein shall have the meaning set forth in the Burlington Stores, Inc. Executive Severance Plan (amended and restated, effective March 17, 2026) (the “Severance

…

** Exhibit 10.1**

SUBORDINATED NOTE PURCHASE AGREEMENT

7.00% FIXED-TO-FLOATING RATE SUBORDINATED NOTE DUE 2036

This SUBORDINATED NOTE PURCHASE AGREEMENT (this “Agreement”) is dated as of August 26, 2026, and is made by and among Avidbank Holdings, Inc., a California corporation (the “Company”), and the several purchasers of the Subordinated Notes (as defined herein) identified on the signature pages hereto (each a “Purchaser” and collectively, the “Purchasers”).

RECITALS

**WHEREAS, **the Company has requested that the Purchasers purchase from the Company up to $30,000,000 in aggregate principal amount of Subordinated Notes, which aggregate amount is intended to qualify for inclusion as Tier 2 Capital (as defined herein);

**WHEREAS, **the Company has engaged Piper Sandler & Co., as its exclusive placement agent (“Placement Agent”) for the offering of the Subordinated Notes;

…

​

BOOT BARN HOLDINGS, INC.

2026 EQUITY INCENTIVE PLAN

​

1

---

TABLE OF CONTENTS

​

	​ ​ ​		Page
1.		Effectiveness and Purpose	3
2.		Definitions	3
3.		Administration	6
4.		Awards	7
5.		Shares Subject to the Plan.	7
6.		Eligibility for Participation	8
7.		Options	9
8.		Stock Awards	10
9.		Stock Units	10
10.		Stock Appreciation Rights	11

…

EXECUTIVE EMPLOYMENT AGREEMENT

This Executive Employment Agreement (this “Agreement”) effective as of September 1, 2026 (“Effective Date”) is entered into between Outlook Therapeutics, Inc., a Delaware corporation with its principal place of business at 111 S. Wood, Avenue, Unit #100, Iselin, New Jersey 08830 (the “Company”) and Kevin Lundquist, residing at [intentionally redacted](the “Executive”).

In consideration of the promises and the terms and conditions set forth in this Agreement, the parties agree as follows:

…

August 27, 2026

Lawrence A. Kenyon

Dear Larry:

In accordance with the Amended and Restated Executive Employment Agreement, dated as of June 2, 2022 (“Employment Agreement”), entered into between you and Outlook Therapeutics, Inc. (the “Company”), this letter sets out the substance of the separation agreement (the “Agreement”) that the Company is offering you to aid in your employment transition. Any capitalized terms in this Separation Agreement will take their meaning from the Employment Agreement unless otherwise defined herein.

…